These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Therapeutic approaches targeting the prion receptor LRP/LR. Zuber C; Ludewigs H; Weiss S Vet Microbiol; 2007 Aug; 123(4):387-93. PubMed ID: 17498894 [TBL] [Abstract][Full Text] [Related]
33. New hospital disinfection processes for both conventional and prion infectious agents compatible with thermosensitive medical equipment. Lehmann S; Pastore M; Rogez-Kreuz C; Richard M; Belondrade M; Rauwel G; Durand F; Yousfi R; Criquelion J; Clayette P; Perret-Liaudet A J Hosp Infect; 2009 Aug; 72(4):342-50. PubMed ID: 19541387 [TBL] [Abstract][Full Text] [Related]
34. Redox metals and oxidative abnormalities in human prion diseases. Petersen RB; Siedlak SL; Lee HG; Kim YS; Nunomura A; Tagliavini F; Ghetti B; Cras P; Moreira PI; Castellani RJ; Guentchev M; Budka H; Ironside JW; Gambetti P; Smith MA; Perry G Acta Neuropathol; 2005 Sep; 110(3):232-8. PubMed ID: 16096758 [TBL] [Abstract][Full Text] [Related]
35. Dental practice implications of prion diseases. Bebermeyer RD; Powell JF; Hobdell MH; Durban EM Quintessence Int; 2003 Jan; 34(1):38-44. PubMed ID: 12674357 [TBL] [Abstract][Full Text] [Related]
39. A new mechanism broadening the role of prion proteins in neurodegeneration. Doyle D; Rogers M Trends Genet; 1998 May; 14(5):171-3. PubMed ID: 9613198 [No Abstract] [Full Text] [Related]